The sleep apnea devices market was valued at US$ 4,033.0 million in 2016 and it is projected to reach US$ 8,305.3 million in 2025; it is expected to grow at a CAGR of 7.9% from 2016 to 2025.
The sleep apnea devices market was valued at US$ 4,033.0 million in 2016 and it is projected to reach US$ 8,305.3 million in 2025; it is expected to grow at a CAGR of 7.9% from 2016 to 2025.
Sleep apnea is a sleep disorder which results into loud snoring. These are mainly caused because of the reasons those are throat muscle relaxing and when the brain stops transmitting signals to the breathing muscles. The symptoms shown by the person having sleep apnea are loud snoring, variations in breathing, awaking in between of sleep, lack of attention, excess of daytime sleep, irritability and lack of sleep during night. The growth of the global sleep apnea devices market is attributed to the technological advancements, rising geriatric population and the declining prices of sleep apnea devices are likely to have a positive impact on the growth of the market in the coming years. However, absence of patient compliance is the major factor hindering the market growth.
Request for sample Copy at: https://www.theinsightpartners.com/sample/TIPHE100000846/
Sleep apnea devices market Segmentation:
- In terms of diagnostic devices, the global sleep apnea devices market is segmented into polysomnography devices, respiratory polygraphs, actigraphy system and oximeters. In 2017, the polysomnography segment held larger share of the market. Also, the same segment is expected to retain its dominance during the forecast period.
- Based on therapeutic devices, the global sleep apnea devices market is segmented into facial interfaces, adaptive servo- ventilation instruments (ASV), positive airway pressure (PAP) devices, oxygen concentrators, airway clearance systems, oral appliances, and accessories. The positive airway pressure segment held the largest market share in 2017, and the same segment is estimated to register the highest CAGR during the forecast period.
- In terms of end user, the global sleep apnea devices market is segmented into home healthcare, sleep laboratories and hospitals. The sleep laboratories and hospitals segment held the largest share of the market in 2017, and it is further estimated to retain its dominance during the forecast period.
- Braebon Medical Corporation, Compumedics Limited, BMC Medical Co., Ltd, Fisher & Paykel Healthcare Limited, ResMed, SomnoMed Limited, Weinmann Emergency Medical Technology, Devilbiss Healthcare LLC., Koninklijke Philips N.V. and Whole You, Inc. are among the leading companies operating in the global sleep apnea devices market.
Increased Usage of Oral Devices to Drive Global Sleep Apnea Devices Market Growth
Obstructive sleep apnea (OSA) is a normal and very common disorder which is categorized by the repetitive, complete or partial closure of the upper airway while sleep that is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes the significant morbidity, especially in terms of impairment of daytime functioning and the impact this has on quality of life. The recent indication from the controlled trials is the proof for the oral appliance therapy which is very effective in controlling OSA in up to 50.0% of patients, which includes some patient with more severe forms of OSA. This is associated with a significant improvement in symptoms, including snoring and daytime sleepiness. This evidence is strong for short term, and emerging for long-term treatment of OSA with oral appliances. Various companies have developed their products for the treatment of sleep apnea and the related accessories. For instance, SomnoDent devices developed by SomnoMed Limited, has increased in the previous year, 2016 from 68% to 68.6%, which signifies that the products have achieved on the signature-line of products. Additionally, SomnoDent Alpha has developed and received FDA approval in September 2016. The Alpha is an instant fit device, used in the sleep clinics for offering the patient and deliver efficacy data of a continuous open airway therapy (COAT) treatment relating to a specific patient before a device is custom made for the patient.
Owing to the rising usage of the oral devices in the various regions, the need and demand for the improved and advanced oral devices for the treatment of the OSA and it increases the market in the future years.
Purchase a copy of the report @ https://www.theinsightpartners.com/buy/TIPHE100000846/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com